SyntekaBio Statistics

Total Valuation

SyntekaBio has a market cap or net worth of KRW 118.25 billion. The enterprise value is 124.78 billion.

Market Cap	118.25B
Enterprise Value	124.78B

Important Dates

The next estimated earnings date is Thursday, August 14, 2025.

Earnings Date	Aug 14, 2025
Ex-Dividend Date	n/a

Share Statistics

SyntekaBio has 15.26 million shares outstanding. The number of shares has increased by 3.47% in one year.

Current Share Class	15.26M
Shares Outstanding	15.26M
Shares Change (YoY)	+3.47%
Shares Change (QoQ)	+9.01%
Owned by Insiders (%)	17.18%
Owned by Institutions (%)	1.92%
Float	12.64M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	120.24
PB Ratio	6.67
P/TBV Ratio	6.82
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-9.22
EV / Sales	126.88
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-9.47

Financial Position

The company has a current ratio of 0.54, with a Debt / Equity ratio of 1.02.

Current Ratio	0.54
Quick Ratio	0.51
Debt / Equity	1.02
Debt / EBITDA	n/a
Debt / FCF	-1.37
Interest Coverage	-5.68

Financial Efficiency

Return on equity (ROE) is -55.82% and return on invested capital (ROIC) is -25.47%.

Return on Equity (ROE)	-55.82%
Return on Assets (ROA)	-19.37%
Return on Invested Capital (ROIC)	-25.47%
Return on Capital Employed (ROCE)	-69.92%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.02
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +2.59% in the last 52 weeks. The beta is 0.48, so SyntekaBio's price volatility has been lower than the market average.

Beta (5Y)	0.48
52-Week Price Change	+2.59%
50-Day Moving Average	7,690.80
200-Day Moving Average	6,640.73
Relative Strength Index (RSI)	45.80
Average Volume (20 Days)	191,952

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, SyntekaBio had revenue of KRW 983.48 million and -13.53 billion in losses. Loss per share was -886.84.

Revenue	983.48M
Gross Profit	979.00M
Operating Income	-14.02B
Pretax Income	-13.53B
Net Income	-13.53B
EBITDA	-11.77B
EBIT	-14.02B
Loss Per Share	-886.84

Full Income Statement

Balance Sheet

The company has 11.57 billion in cash and 18.10 billion in debt, giving a net cash position of -6.53 billion or -427.96 per share.

Cash & Cash Equivalents	11.57B
Total Debt	18.10B
Net Cash	-6.53B
Net Cash Per Share	-427.96
Equity (Book Value)	17.73B
Book Value Per Share	1,162.08
Working Capital	-10.55B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -10.77 billion and capital expenditures -2.42 billion, giving a free cash flow of -13.18 billion.

Operating Cash Flow	-10.77B
Capital Expenditures	-2.42B
Free Cash Flow	-13.18B
FCF Per Share	-863.96

Full Cash Flow Statement

Margins

Gross Margin	99.54%
Operating Margin	-1,425.24%
Pretax Margin	-1,375.93%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

SyntekaBio does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-3.47%
Shareholder Yield	n/a
Earnings Yield	-11.44%
FCF Yield	-11.15%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

SyntekaBio has an Altman Z-Score of -1.46 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-1.46
Piotroski F-Score	3